Literature DB >> 7252243

Photoradiation therapy for cutaneous and subcutaneous malignancies.

T J Dougherty.   

Abstract

Photoradiation therapy (PRT) using hematoporphyrin derivative (Hpd) as the photosensitizing agent is being developed for local treatment of a wide variety of malignant lesions including those involving the skin. The largest group of patients in this category are those with metastatic breast carcinoma in which 34/35 showed response to PRT. Other patients showing response to PRT are those with basal cell carcinoma, malignant melanoma, and squamous cell carcinoma.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7252243     DOI： 10.1111/1523-1747.ep12479341

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  9 in total

Review 1.  Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives.

Authors:  F S De Rosa; M V Bentley
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  Photodynamic therapy of rat liver cancer: protection of the normal liver by indocyanine green.

Authors:  K Kita; T Itoshima; T Ito; H Ogawa; M Ukida; M Kitadai; S Hattori; S Mizutani; R Tanaka; M Andoh
Journal:  Gastroenterol Jpn       Date:  1987-08

3.  Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase.

Authors:  H A Dailey; A Smith
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

4.  Pulsed versus continuous wave excitation mechanisms in photodynamic therapy of differently graded squamous cell carcinomas in tumor-implanted nude mice.

Authors:  P C Rausch; F Rolfs; M R Winkler; A Kottysch; A Schauer; W Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

5.  The effect of combined modality treatment with ionising radiation and TPPS-mediated photodynamic therapy on murine tail skin.

Authors:  K Benstead; J V Moore
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

6.  Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice.

Authors:  G Jori; E Reddi; I Cozzani; L Tomio
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

7.  Vascular function and the probability of skin necrosis after photodynamic therapy: an experimental study.

Authors:  K Benstead; J V Moore
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

8.  The effect of fractionation of light treatment on necrosis and vascular function of normal skin following photodynamic therapy.

Authors:  K Benstead; J V Moore
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

9.  Photodynamic therapy using a diode laser with mono-L-aspartyl chlorin e6 for implanted fibrosarcoma in mice.

Authors:  T Katsumi; K Aizawa; T Okunaka; Y Kuroiwa; Y Ii; K Saito; C Konaka; H Kato
Journal:  Jpn J Cancer Res       Date:  1994-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.